Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nadolol vs Propranolol in Infantile Hemangiomas
NCT02505971Phase 3Completed
- Sponsor
- SickKids
- Start
- Sep 2015
- Primary completion
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of nadolol in infantile hemangioma (IH) (2 arms), sponsored by SickKids. Primary endpoint: Change in the bulk (size/extent) and color of the infantile hemangioma at 24 weeks. Started Sep 2015; status: completed.
02
Drugs
nadolol
03
Conditions
infantile hemangioma (IH)
Beyond the preview
Go deeper on NCT02505971.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02505971.